- $117.58m
- $100.07m
- $54.54m
- 58
- 93
- 31
- 63
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 36.3 | 40.2 | 49 | 54 | 47.9 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 35.5 | 38.2 | 48.8 | 52.1 | 46 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 13.4 | 18.6 | 26 | 24.6 | 15.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 11.1 | 15.3 | 21.4 | 20.4 | 13 |
Net Income Before Extraordinary Items | |||||
Net Income | 11.1 | 15.3 | 21.4 | 20.4 | 13 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 11.1 | 15.3 | 21.4 | 20.4 | 13 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.559 | 0.845 | 1.07 | 1.11 | 0.719 |
Dividends per Share |